Publicacións nas que colabora con Isabel Martín Herranz (40)

2024

  1. Observational Study to Compare Biological Drug Concentration Quantification Techniques and Immunogenicity in Patients with Immune-Mediated Diseases

    Biomedicines, Vol. 12, Núm. 4

2023

  1. Artículo traducido] Prevalencia de reacciones adversas a medicamentos asociadas a visitas al servicio de urgencias y factores de riesgo de hospitalización

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 47, Núm. 1, pp. T20-T25

  2. Lipid profile changes associated with antiretroviral therapies in a real-world cohort

    Farmacia Hospitalaria, Vol. 47, Núm. 5, pp. 210-217

  3. Medication reconciliation for patients after their discharge from intensive care unit to the hospital ward

    Farmacia Hospitalaria, Vol. 47, Núm. 3, pp. T121-T126

  4. Renal profile of patients treated with elvitegravir/ cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort

    European Journal of Hospital Pharmacy, Vol. 30, Núm. 4, pp. 221-226

  5. Treatment of high-risk bleeding with susoctocog alfa in a patient with acquired haemophilia A and a nosocomial severe acute respiratory syndrome coronavirus 2 infection

    European Journal of Hospital Pharmacy, Vol. 30, Núm. 3, pp. 177-179

2022

  1. Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago

    Dermatology and Therapy, Vol. 12, Núm. 3, pp. 761-770

  2. Discontinuation due to neuropsychiatric adverse events with efavirenz-and dolutegravir-based antiretroviral therapy: a comparative real-life study

    European Journal of Hospital Pharmacy, Vol. 29, Núm. 4, pp. 207-211

  3. Real-world use of ustekinumab therapeutic drug monitoring in moderate to severe psoriasis

    Frontiers in Medicine, Vol. 9

2021

  1. Continuous infusion of antibiotics using elastomeric pumps in the hospital at home setting

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 34, Núm. 3, pp. 200-206

  2. Development of the @Antidotos_bot chatbot tool for poisoning management

    Farmacia Hospitalaria, Vol. 45, Núm. 4, pp. 180-183

  3. E-Interconsultations between a hospital pharmacy service and primary care pharmacy units in Spain

    European Journal of Hospital Pharmacy, Vol. 28, Núm. 4, pp. 202-206

  4. Influence of drug-drug interactions on effectiveness and safety of direct-acting antivirals against hepatitis C virus

    European Journal of Hospital Pharmacy, Vol. 28, Núm. 1, pp. 16-21

  5. Results of the implementation of a pharmacogenomics platform based on NGS technologies. Combining clinical and research approaches

    Farmacia Hospitalaria, Vol. 45, pp. 11-37

2020

  1. A case of severe hypothermia following three-month administration of paliperidone palmitate: a case report

    Actas espanolas de psiquiatria, Vol. 48, Núm. 4, pp. 181-190

  2. Effectiveness and safety of direct-acting antivirals in hepatitis C infected patients with mental disorders: Results in real clinical practice

    Journal of Medical Virology, Vol. 92, Núm. 12, pp. 3488-3498

  3. Effectiveness and safety of sofosbuvir/velpatasvir ± ribavirin vs glecaprevir/pibrentasvir in genotype 3 hepatitis C virus infected patients

    European Journal of Hospital Pharmacy

  4. Hipotermia grave tras administración de paliperidona depot: A propósito de un caso

    Actas Espanolas de Psiquiatria

  5. Impact of introducing assisted electronic prescription on paediatric patient safety

    Anales de Pediatria, Vol. 93, Núm. 2, pp. 103-110

2019

  1. Effectiveness and safety of daclatasvir/sofosbuvir with or without ribavirin in genotype 3 hepatitis c virus infected patients. Results in real clinical practice

    Revista Espanola de Quimioterapia, Vol. 32, Núm. 2, pp. 137-144